Clinical Trial Update: Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial of imetelstat in patients with previously treated multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Geron Corporation | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED